167 related articles for article (PubMed ID: 24016674)
1. Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.
Van Praet C; Ost P; Lumen N; De Meerleer G; Vandecasteele K; Villeirs G; Decaestecker K; Fonteyne V
Radiother Oncol; 2013 Nov; 109(2):222-8. PubMed ID: 24016674
[TBL] [Abstract][Full Text] [Related]
2. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
3. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer.
Cozzarini C; Fiorino C; Di Muzio N; Alongi F; Broggi S; Cattaneo M; Montorsi F; Rigatti P; Calandrino R; Fazio F
Radiother Oncol; 2007 Aug; 84(2):164-70. PubMed ID: 17706308
[TBL] [Abstract][Full Text] [Related]
4. Helical tomotherapy with simultaneous integrated boost for high-risk and lymph node-positive prostate cancer: early report on acute and late toxicity.
Engels B; Soete G; Tournel K; Bral S; De Coninck P; Verellen D; Storme G
Technol Cancer Res Treat; 2009 Oct; 8(5):353-59. PubMed ID: 19754211
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome.
Fonteyne V; Lumen N; Ost P; Van Praet C; Vandecasteele K; De Gersem Ir W; Villeirs G; De Neve W; Decaestecker K; De Meerleer G
Radiother Oncol; 2013 Nov; 109(2):229-34. PubMed ID: 24016677
[TBL] [Abstract][Full Text] [Related]
6. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
[TBL] [Abstract][Full Text] [Related]
7. Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer - a retrospective analysis of dose-escalated patients.
Link C; Honeck P; Makabe A; Giordano FA; Bolenz C; Schaefer J; Bohrer M; Lohr F; Wenz F; Buergy D
Radiat Oncol; 2019 Jun; 14(1):96. PubMed ID: 31174555
[TBL] [Abstract][Full Text] [Related]
8. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
9. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
10. Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis.
Song C; Byun SJ; Kim YS; Ahn H; Byun SS; Kim CS; Lee SE; Kim JS
PLoS One; 2019; 14(4):e0215057. PubMed ID: 30973905
[TBL] [Abstract][Full Text] [Related]
11. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821
[TBL] [Abstract][Full Text] [Related]
12. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
[TBL] [Abstract][Full Text] [Related]
13. Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trial.
Habl G; Katayama S; Uhl M; Kessel KA; Edler L; Debus J; Herfarth K; Sterzing F
BMC Cancer; 2015 Nov; 15():868. PubMed ID: 26547188
[TBL] [Abstract][Full Text] [Related]
14. Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
Chen MJ; Weltman E; Hanriot RM; Luz FP; Cecílio PJ; da Cruz JC; Moreira FR; Santos AS; Martins LC; Nadalin W
Radiat Oncol; 2007 Jan; 2():6. PubMed ID: 17224072
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
Ramey SJ; Agrawal S; Abramowitz MC; Moghanaki D; Pisansky TM; Efstathiou JA; Michalski JM; Spratt DE; Hearn JWD; Koontz BF; Liauw SL; Pollack A; Anscher MS; Den RB; Stephans KL; Zietman AL; Lee WR; Stephenson AJ; Tendulkar RD
Eur Urol; 2018 Jul; 74(1):99-106. PubMed ID: 29128208
[TBL] [Abstract][Full Text] [Related]
17. Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy.
Longobardi B; Berardi G; Fiorino C; Alongi F; Cozzarini C; Deli A; La Macchia M; Perna L; Di Muzio NG; Calandrino R
Radiother Oncol; 2011 Dec; 101(3):460-4. PubMed ID: 21864924
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
Pinkawa M; Piroth MD; Holy R; Fischedick K; Klotz J; Székely-Orbán D; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):23-8. PubMed ID: 20832182
[TBL] [Abstract][Full Text] [Related]
19. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy.
Alongi F; Fiorino C; Cozzarini C; Broggi S; Perna L; Cattaneo GM; Calandrino R; Di Muzio N
Radiother Oncol; 2009 Nov; 93(2):207-12. PubMed ID: 19766338
[TBL] [Abstract][Full Text] [Related]
20. Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy.
Mantini G; Tagliaferri L; Mattiucci GC; Balducci M; Frascino V; Dinapoli N; Di Gesù C; Ippolito E; Morganti AG; Cellini N
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e721-6. PubMed ID: 21277100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
